Monaco reinforces global commitment to fighting sickle cell disease
By MonacoViews Editorial, MonacoViews Editorial
Monaco is reinforcing its long-standing commitment to tackling sickle cell disease, a little-known but widespread genetic condition affecting an estimated 120 million people worldwide... Particularly prevalent in Africa, the disease remains a major public health challenge in countries such as Senegal, where around 10 percent of the population carries the gene and approximately 2,000 children MC - M
Monaco is strengthening its dedication to combating sickle cell disease, a genetic condition that affects an estimated 120 million people worldwide yet remains relatively unknown to many.
The disease presents a particularly acute challenge in Africa, where it has reached epidemic proportions in several countries. In Senegal, for example, around 10 percent of the population carries the gene, with approximately 2,000 children affected by this debilitating condition.
Sickle cell disease causes red blood cells to become misshapen, leading to severe pain, organ damage, and reduced life expectancy. Despite its significant global impact, the condition has historically received limited attention and resources compared to other health challenges.
Monaco's renewed focus on this issue reflects the Principality's ongoing commitment to international health initiatives and its role in supporting medical research and humanitarian efforts on a global scale.